Tyche Wealth Partners LLC Buys Shares of 2,273 CME Group Inc. $CME

Tyche Wealth Partners LLC bought a new stake in shares of CME Group Inc. (NASDAQ:CME) in the 4th quarter, HoldingsChannel reports. The fund bought 2,273 shares of the financial services provider’s stock, valued at approximately $621,000.

Several other institutional investors have also recently added to or reduced their stakes in the business. Caldwell Trust Co grew its position in shares of CME Group by 116.3% during the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock worth $25,000 after acquiring an additional 50 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA bought a new position in shares of CME Group during the third quarter worth about $27,000. FNY Investment Advisers LLC bought a new position in shares of CME Group during the fourth quarter worth about $27,000. Financial Consulate Inc. bought a new position in shares of CME Group during the third quarter worth about $28,000. Finally, Corundum Trust Company INC bought a new position in shares of CME Group during the third quarter worth about $30,000. Institutional investors own 87.75% of the company’s stock.

CME Group Price Performance

Shares of NASDAQ:CME traded down $2.65 during trading on Tuesday, reaching $297.94. The company had a trading volume of 123,145 shares, compared to its average volume of 2,252,872. The firm’s fifty day moving average is $306.56 and its 200 day moving average is $284.92. The firm has a market capitalization of $106.85 billion, a PE ratio of 26.70, a price-to-earnings-growth ratio of 3.08 and a beta of 0.26. CME Group Inc. has a twelve month low of $251.90 and a twelve month high of $329.16. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.03 and a current ratio of 1.03.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, topping analysts’ consensus estimates of $2.75 by $0.02. The company had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.64 billion. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The business’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same period in the prior year, the business posted $2.52 EPS. On average, equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th were issued a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend was Tuesday, March 10th. This is a positive change from CME Group’s previous quarterly dividend of $1.25. CME Group’s dividend payout ratio is currently 46.59%.

Insider Buying and Selling at CME Group

In other CME Group news, General Counsel Jonathan L. Marcus sold 3,291 shares of the company’s stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total value of $1,097,120.67. Following the completion of the sale, the general counsel directly owned 7,192 shares of the company’s stock, valued at approximately $2,397,597.04. This represents a 31.39% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Bryan T. Durkin sold 4,200 shares of the company’s stock in a transaction dated Monday, February 23rd. The shares were sold at an average price of $309.65, for a total transaction of $1,300,530.00. Following the completion of the sale, the director directly owned 43,007 shares of the company’s stock, valued at $13,317,117.55. The trade was a 8.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 8,539 shares of company stock valued at $2,713,821 over the last 90 days. Insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently commented on CME. Royal Bank Of Canada upped their price target on shares of CME Group from $295.00 to $302.00 and gave the stock a “sector perform” rating in a research report on Thursday, February 5th. Raymond James Financial upped their price target on shares of CME Group from $310.00 to $320.00 and gave the stock an “outperform” rating in a research report on Monday, April 6th. UBS Group restated a “neutral” rating and set a $310.00 price target on shares of CME Group in a research report on Friday, February 6th. Deutsche Bank Aktiengesellschaft upped their price target on shares of CME Group from $312.00 to $316.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. Finally, Barclays decreased their target price on shares of CME Group from $344.00 to $343.00 and set an “equal weight” rating for the company in a research report on Monday. Two investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $308.71.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.